Cross-section of a solid tumour; Afinitor is undergoing clinical trials as a treatment for various tumours of this type. Afinitor has been approved for the treatment of renal cell cancer and advanced neuroendocrine tumours of pancreatic gastrointestinal, lung or pancreatic origin.
-
Cross-section of a solid tumour; Afinitor is undergoing clinical trials as a... -
When the tumour is confined to the kidney, renal cell cancer may be... -
The lungs and soft tissues are the most common secondary sites of renal cell...
